NO20070434L - Polysakkaridderivater og anvendelser ved induksjon av en immunrespons - Google Patents

Polysakkaridderivater og anvendelser ved induksjon av en immunrespons

Info

Publication number
NO20070434L
NO20070434L NO20070434A NO20070434A NO20070434L NO 20070434 L NO20070434 L NO 20070434L NO 20070434 A NO20070434 A NO 20070434A NO 20070434 A NO20070434 A NO 20070434A NO 20070434 L NO20070434 L NO 20070434L
Authority
NO
Norway
Prior art keywords
acetylated
derivative
induction
applications
immune response
Prior art date
Application number
NO20070434A
Other languages
English (en)
Inventor
Gregory R Moe
Dan M Granoff
Original Assignee
Childrens Hosp & Res Ct Oak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp & Res Ct Oak filed Critical Childrens Hosp & Res Ct Oak
Publication of NO20070434L publication Critical patent/NO20070434L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Den foreliggende oppfinnelsen tilveiebringer generelt sammensetninger som omfatter et polysakkaridderivat og fremgangsmåter for deres tillaging og anvendelse for forebyggingen eller behandlingen av sykdommer forårsaket av Neisseria meningitidisbakterier, spesielt gruppe B8NmB)-stammer og av E coli Kl. Oppfinnelsen tilveiebringer et de-N-acetylert PS-derivat hvor ett eller flere residuer i PS-et er blitt modifisert ved de-N-acetylering. Oppfinnelsen inkluderer også derivater hvor én eller flere av N-acetylgruppene i PS som inneholder de-N-acetylert PS, er erstattet med andre N-acylgrupper, vanligvis en lavere acylgruppe av C2- C3. Oppfinnelsen inkluderer videre de-N-acetylerte PS-derivater som inneholder langkjedede hydrokarboner, så vel som konjugater hvor det de-N-acetylerte PS-derivatet er koblet til en bærer, for eksempel et bærerprotein.
NO20070434A 2004-06-23 2007-01-23 Polysakkaridderivater og anvendelser ved induksjon av en immunrespons NO20070434L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58267204P 2004-06-23 2004-06-23
PCT/US2005/022590 WO2006002402A2 (en) 2004-06-23 2005-06-23 Polysaccharide derivatives and uses in induction of an immune response

Publications (1)

Publication Number Publication Date
NO20070434L true NO20070434L (no) 2007-03-20

Family

ID=35782376

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070434A NO20070434L (no) 2004-06-23 2007-01-23 Polysakkaridderivater og anvendelser ved induksjon av en immunrespons

Country Status (14)

Country Link
US (2) US7595307B2 (no)
EP (1) EP1784428A2 (no)
JP (1) JP2008509886A (no)
KR (1) KR20070060069A (no)
AU (1) AU2005258301A1 (no)
BR (1) BRPI0512413A (no)
CA (1) CA2568982A1 (no)
CR (1) CR8862A (no)
EC (1) ECSP077129A (no)
IL (1) IL179642A0 (no)
MX (1) MXPA06015107A (no)
NO (1) NO20070434L (no)
RU (1) RU2404995C2 (no)
WO (1) WO2006002402A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
MXPA06015107A (es) 2004-06-23 2007-03-26 Childrens Hosp & Res Ct Oak Derivados de polisacaridos y sus usos en la induccion de una respuesta inmune.
US20090136547A1 (en) * 2005-08-24 2009-05-28 Novartis Vaccines And Diagnostics Srl Zwitterionization of capsular saccharides
JP5384941B2 (ja) * 2005-12-23 2014-01-08 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド 脱アセチル化シアル酸抗原、これに対する抗体、及び癌療法における使用方法。
AU2008265767B2 (en) * 2007-06-20 2014-11-13 Pfizer Ireland Pharmaceuticals Modified polysaccharides for conjugate vaccines
EP2183261A4 (en) 2007-07-03 2010-09-15 Childrens Hosp & Res Ct Oak POLYSIALYLIC ACID DERIVATIVES, MANUFACTURING METHODS AND APPLICATIONS FOR INCREASING THE PRODUCTION AND TARGETING OF CANCER ANIMALS
EP2173166A4 (en) * 2007-07-03 2010-08-11 Childrens Hosp & Res Ct Oak POLYSIALIC ACID DE-N-ACETYLASE HEMMER AND METHOD OF USE THEREOF
WO2009006620A1 (en) * 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
US20130116423A1 (en) 2010-04-23 2013-05-09 A. Stewart Campbell Synthetic Oligosaccharides for Staphylococcus Vaccine
WO2011137181A1 (en) 2010-04-27 2011-11-03 Ancora Pharmaceuticals Inc. Synthetic oligosaccharides for moraxella vaccine
WO2011149778A1 (en) * 2010-05-26 2011-12-01 Ancora Pharmaceuticals Inc. Synthetic oligosaccharides for neisseria meningitis vaccine
CN109182423B (zh) * 2018-09-26 2020-07-07 武汉中科光谷绿色生物技术有限公司 促进大肠杆菌发酵生产聚唾液酸的方法
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
CN114539333B (zh) * 2022-03-01 2023-12-22 德元堂(上海)健康科技发展有限公司 一种唾液酸的循环生产工艺
CN114507262B (zh) * 2022-03-01 2023-12-19 德元堂(上海)健康科技发展有限公司 一种聚唾液酸的水解工艺

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216208A (en) * 1978-07-31 1980-08-05 Proter S.P.A. N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
US4314999A (en) * 1978-07-31 1982-02-09 Proter S.P.A. N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity
US4727136A (en) 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
US4722136A (en) * 1985-10-28 1988-02-02 Leviton Manufacturing Company, Inc. Snap-in convenience electrical connector system and method of assembly
JPS6344590A (ja) * 1986-08-12 1988-02-25 Mect Corp シアル酸誘導体の製造方法
RO111416B1 (ro) 1989-12-14 1996-10-31 Ca Nat Research Council Polizaharide modificate de neisseria meningitidis si e coli, combinatii antigenice si metoda de imunizare
US5846951A (en) * 1991-06-06 1998-12-08 The School Of Pharmacy, University Of London Pharmaceutical compositions
GB9116896D0 (en) * 1991-08-06 1991-09-18 Erba Carlo Spa 3-deoxymannosamine derivatives and process for their preparation
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
JPH101397A (ja) * 1996-06-14 1998-01-06 Mitsubishi Gas Chem Co Inc 磁気光学素子の基板用ガーネット結晶及びその製造法
DK0939647T4 (da) * 1996-08-27 2006-10-23 Novartis Vaccines & Diagnostic Neisseria Meningitidis-serogruppe B-glycokonjugat og fremgangsmåde til anvendelse deraf
CA2264585C (en) * 1996-08-27 2005-06-14 Chiron Corporation Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
AU9120898A (en) 1997-08-27 1999-03-16 Chiron Corporation Molecular mimetics of meningococcal b epitopes
AU5339699A (en) * 1998-08-06 2000-02-28 Johns Hopkins University School Of Medicine, The Compounds for altering cell surface sialic acids and methods of use therefor
CA2279134A1 (en) * 1999-07-29 2001-01-29 Tianmin Liu Novel strategy for carbohydrate-based therapeutic vaccines
EP1307221A2 (en) * 2000-07-28 2003-05-07 National Research Council of Canada Modified sialic acid vaccines
MXPA06015107A (es) 2004-06-23 2007-03-26 Childrens Hosp & Res Ct Oak Derivados de polisacaridos y sus usos en la induccion de una respuesta inmune.

Also Published As

Publication number Publication date
IL179642A0 (en) 2007-05-15
JP2008509886A (ja) 2008-04-03
WO2006002402A3 (en) 2006-05-04
RU2404995C2 (ru) 2010-11-27
CR8862A (es) 2007-07-24
EP1784428A2 (en) 2007-05-16
ECSP077129A (no) 2007-02-28
US20070010482A1 (en) 2007-01-11
CA2568982A1 (en) 2006-01-05
RU2007102255A (ru) 2008-07-27
US20100068728A1 (en) 2010-03-18
AU2005258301A1 (en) 2006-01-05
WO2006002402A2 (en) 2006-01-05
BRPI0512413A (pt) 2008-03-04
US7595307B2 (en) 2009-09-29
KR20070060069A (ko) 2007-06-12
MXPA06015107A (es) 2007-03-26

Similar Documents

Publication Publication Date Title
NO20070434L (no) Polysakkaridderivater og anvendelser ved induksjon av en immunrespons
BRPI0607374B8 (pt) vacinas de vesículas baseadas em gna1870 para proteção de amplo espectro contra doenças causadas por neisseria meningitidis
EA201101164A1 (ru) Иммуногенная композиция
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
DK0939647T4 (da) Neisseria Meningitidis-serogruppe B-glycokonjugat og fremgangsmåde til anvendelse deraf
NO20052071L (no) Bezofuranforbindelser, preparater og metoder for behandling og forebygging av hepatitt C virale infeksjoner og relaterte sykdommer.
EA200600041A1 (ru) Применение изомальта (смеси 1,6-gps и 1,1-gpm) в качестве пребиотика, в частности, для получения лекарственного средства для лечения кишечных заболеваний
NO20083845L (no) 2,4-diaminopyrimidiner som celle-cyklus kinase inhibitorer
BRPI0412897A (pt) compostos heterocìclicos como bloqueadores de canal de ìons p2x7
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
EA200601670A1 (ru) Конъюгаты гидроксиалкилкрахмала и белка
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
NO20045281L (no) Tiazolidinoner og anvendelse derav som polo-lignende kinaseinhibitorer
MXPA05011110A (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos.
NO20065320L (no) Imidazolderivater anvendt som tafiainhibitorer
MX2009013676A (es) Metodos y composiciones para inhibir el factor de edema y la adenilil ciclasa.
NO20080943L (no) Fremstilling av krystallinsk kortkjedet amylose
NO20060821L (no) Heparinavledede oligosakkaridblandinger, fremstilling derav og farmasoytiske preparater inneholdende nevnte blandinger
NO20054778L (no) Farmasoytiske sammensetninger som innbefatter en kombinasjon av rapamycin eller dets derivat og pimecrolimus for behandling av inflamasjon- og immunologisk-medierte sykdommer
BRPI0516770A (pt) vacina e conjugados de proteìna - derivados de polissacarìdeo de meningocócico multivalente
NO20072854L (no) Acylerte nonadepsipeptider anvendt som lysobaktinderivater
BRPI0515125A (pt) conjugados de polissacarìdeo derivatizado-proteìna multivalentes, meningocócicos e vacina
MX2010009147A (es) Derivados de pirrolidinilo y usos de los mismos.
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application